Biosimilar Landscape in 2024

Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond

The anticipated expiration of exclusivity rights for major biologics in 2022…


How Gene Therapy sponsors can overcome regulatory approval bottlenecks.

How Gene Therapy sponsors can overcome regulatory approval bottlenecks.

In a previous article, we discussed the findings of a Linkedin poll regarding…